SpringerLink
Log in

A Novel RAC2 Variant Presenting as Severe Combined Immunodeficiency

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Lagresle-Peyrou C, Olichon A, Sadek H, Roche P, Tardy C, Da Silva C, et al. A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency. Haematologica. 2020.

  2. Ambruso DR, Knall C, Abell AN, Panepinto J, Kurkchubasche A, Thurman G, et al. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A. 2000;97(9):4654–9.

    Article  CAS  Google Scholar 

  3. Accetta D, Syverson G, Bonacci B, Reddy S, Bengtson C, Surfus J, et al. Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. J Allergy Clin Immunol. 2011;127(2):535–8 e1–2.

    Article  CAS  Google Scholar 

  4. Alkhairy OK, Rezaei N, Graham RR, Abolhassani H, Borte S, Hultenby K, et al. RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency. J Allergy Clin Immunol. 2015;135(5):1380–4 e1–5.

    Article  CAS  Google Scholar 

  5. Hsu AP, Donkó A, Arrington ME, Swamydas M, Fink D, Das A, et al. Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects. Blood. 2019;133(18):1977–88.

    Article  CAS  Google Scholar 

  6. Lougaris V, Chou J, Beano A, Wallace JG, Baronio M, Gazzurelli L, et al. A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency. J Allergy Clin Immunol. 2019;143(4):1649–53 e3.

    Article  CAS  Google Scholar 

  7. Smits BM, Lelieveld PHC, Ververs FA, Turkenburg M, de Koning C, van Dijk M, et al. A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease. Clin Immunol. 2019;12:108248.

    Google Scholar 

  8. Sharapova SO, Haapaniemi E, Sakovich IS, Kostyuchenko LV, Donkó A, Dulau-Florea A, et al. Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections. Clin Immunol. 2019;205:1–5.

    Article  CAS  Google Scholar 

  9. Cherfils J, Zeghouf M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev. 2013;93(1):269–309.

    Article  CAS  Google Scholar 

  10. Lu S, Jang H, Nussinov R, Zhang J. The structural basis of oncogenic mutations G12, G13 and Q61 in small GTPase K-Ras4B. Sci Rep. 2016;6:21949.

    Article  CAS  Google Scholar 

  11. Burd CE, Liu W, Huynh MV, Waqas MA, Gillahan JE, Clark KS, et al. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. Cancer Discov. 2014;4(12):1418–29.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Allergy and Immunology, Penn State Children’s Hospital, 600 University Drive, Hershey, PA, 17036, USA

    Heather Stern & Doerthe Adriana Andreae

  2. Molecular Defenses Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA

    Agnes Donkó & Thomas L. Leto

  3. Department of Pediatrics, Division of Pediatric Hematology and Oncology, Penn State Children’s Hospital, 600 University Drive, Hershey, PA, 17036, USA

    Teresa Shapiro

  4. Immunopathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA

    Amy P. Hsu & Steven M. Holland

Authors
  1. Heather Stern
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Agnes Donkó
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teresa Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amy P. Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas L. Leto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Steven M. Holland
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Doerthe Adriana Andreae
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Doerthe Adriana Andreae.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stern, H., Donkó, A., Shapiro, T. et al. A Novel RAC2 Variant Presenting as Severe Combined Immunodeficiency. J Clin Immunol 41, 473–476 (2021). https://doi.org/10.1007/s10875-020-00915-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-020-00915-2

Search

Navigation